CIRILLO, FERNANDO

Nome completo

CIRILLO, FERNANDO

Mostra records

Risultati 1 - 5 di 5 (tempo di esecuzione: 0.005 secondi).

High Mobility Group Box 1 (HMGB1) and Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) are increased, Insulin Decreased and IL-6 Unchanged in Follicular Fluid (FF) from Polycystic Ovarian Syndrome (PCOS)

2018-01-01 Cirillo, F; Catellani, C; Lazzeroni, P; Sartori, C; Morini, D; Nicoli, A; Amarri, S; La Sala, Gb; Street, Me

High Mobility Group Box 1 (HMGB1) is Increased in Adolescents with Polycystic Ovarian Syndrome (PCOS) and Decreases After Treatment with Myo-Inositol in Combination with A-Lipoic Acid (MYO plus ALA)

2018-01-01 Cirillo, F; Catellani, C; Tridenti, G; Vezzani, C; Lazzeroni, P; Sartori, C; Fulghesu, Am; Losi, S; Coradazzi, L; Amarri, S; Street, Me

INSULIN SENSITIVITY REGULATING MIRNAS SHOW CHANGES IN GRANULOSA CELLS (GC) FROM POLYCYSTIC OVARY SYNDROME (PCOS) OVARIES

2017-01-01 Cirillo, F; Lazzeroni, P; Sartori, C; Morini, D; Nicoli, A; Rossi, Pg; Amarri, S; La Sala, Gb; Street, Me

MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study

2022-01-01 Catellani, C.; Cirillo, F.; Graziano, S.; Montanini, L.; Marmiroli, N.; Gulli', M.; Street, M. E.

Serum High Mobility Group Box 1 (HMGB1) levels are independently associated with glucose clamp-derived measures of insulin resistance in PCOS

2021-01-01 Catellani, C; Migazzi, M; Sartori, C; Dauriz, M; Righi, B; Cirillo, F; Villani, M; Tosi, F; Moghetti, P; Street, Me

Titolo	Data di pubblicazione	Autore(i)
High Mobility Group Box 1 (HMGB1) and Insulin-Like Growth Factor Binding Protein-2 (IGFBP-2) are increased, Insulin Decreased and IL-6 Unchanged in Follicular Fluid (FF) from Polycystic Ovarian Syndrome (PCOS)	1-gen-2018	Cirillo, F; Catellani, C; Lazzeroni, P; Sartori, C; Morini, D; Nicoli, A; Amarri, S; La Sala, Gb; Street, Me
High Mobility Group Box 1 (HMGB1) is Increased in Adolescents with Polycystic Ovarian Syndrome (PCOS) and Decreases After Treatment with Myo-Inositol in Combination with A-Lipoic Acid (MYO plus ALA)	1-gen-2018	Cirillo, F; Catellani, C; Tridenti, G; Vezzani, C; Lazzeroni, P; Sartori, C; Fulghesu, Am; Losi, S; Coradazzi, L; Amarri, S; Street, Me
INSULIN SENSITIVITY REGULATING MIRNAS SHOW CHANGES IN GRANULOSA CELLS (GC) FROM POLYCYSTIC OVARY SYNDROME (PCOS) OVARIES	1-gen-2017	Cirillo, F; Lazzeroni, P; Sartori, C; Morini, D; Nicoli, A; Rossi, Pg; Amarri, S; La Sala, Gb; Street, Me
MicroRNA global profiling in cystic fibrosis cell lines reveals dysregulated pathways related with inflammation, cancer, growth, glucose and lipid metabolism, and fertility: an exploratory study	1-gen-2022	Catellani, C.; Cirillo, F.; Graziano, S.; Montanini, L.; Marmiroli, N.; Gulli', M.; Street, M. E.
Serum High Mobility Group Box 1 (HMGB1) levels are independently associated with glucose clamp-derived measures of insulin resistance in PCOS	1-gen-2021	Catellani, C; Migazzi, M; Sartori, C; Dauriz, M; Righi, B; Cirillo, F; Villani, M; Tosi, F; Moghetti, P; Street, Me